Ayala Pharmaceuticals Inc (ADXS)

[hovacre]

I'm not an expert in anal cancer, but I think the chemoradiotherapy they used in this situation already has high response rates and good progression-free survival. But it does look at this point like that 34-month DFS could be better than standard therapy. Time will tell.

Also the therapy was quite safe, which is a good sign